Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

51 - 60 of 978 results found

Natalizumab extended interval dosing: what about wearing-off effect?

Date
Sunday, February 18, 2024 - 4:00 AM
Description
CONCLUSION: WO affects a significant proportion of MS patients under natalizumab. Its prevalence, severity, and duration increase on EID, therefore despite clinical effectiveness maintenance of this posology should be individualized.

Natural course of post-COVID symptoms in adults and children

Date
Friday, February 16, 2024 - 4:00 AM
Description
More than 200 million COVID-19 survivors have lasting symptoms after recovering, but the duration and related risk factors remain uncertain. This study focused on all 6551 patients diagnosed with COVID-19 at a medical institution in Hiroshima from

Nanobody engineering for SARS-CoV-2 neutralization and detection

Date
Friday, February 16, 2024 - 4:00 AM
Description
In response to the ongoing COVID-19 pandemic, the quest for coronavirus inhibitors has inspired research on a variety of small proteins beyond conventional antibodies, including robust single-domain antibody fragments, i.e., "nanobodies." Here, we